A team of Singapore scientists has made a significant discovery in understanding stomach cancer, a disease that remains one ...

Imagine a world where bacteria, typically feared for causing disease, are turned into powerful weapons against cancer. That’s exactly what some scientists are working on. And they are beginning to ...

Durable complete response (CR) in a MCC patient treated with 15 mg/kg solnerstotug + cemiplimab. Patient continues on ...

Predictive biomarkers of immunotherapy response are critical for clinical practice. In this study, baseline plasma sCD27 was ...

Glioblastoma, one of the most aggressive and lethal brain cancers, has a five-year survival rate of only 6.9%, according to the National Brain Tumor Society. While the relationship between ...

The hub will evaluate how emerging therapeutics, including GLP-1 agonists, might impact cancer progression and treatment.

About Portage Biotech Portage Biotech is a clinical-stage immuno-oncology company advancing a pipeline of novel biologics to transform the immune system’s ability to fight cancer. For more information ...

Investing.com -- Shares of Portage Biotech Inc. (NASDAQ: PRTG) surged 29% following the presentation of new preclinical data for its mesothelioma treatment, PORT-7. The company unveiled these findings ...

Sandy Weill on Thursday announced a new $50 million donation to create a cancer research and treatment hub focused on ...

Pembrolizumab and XL888 in advanced CRC showed manageable safety, though limited responses and potential immunomodulatory ...

"Penetrium introduces an innovative anticancer strategy, neutralizing ECM barriers that block effective drug and immune cell ...